Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 360° synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing use of opioid prescriptions
3.2.1.2 Rising incidence of pain related disorders
3.2.1.3 Advantages offered by non-opioid pain patches over other forms of medications
3.2.1.4 Rising R&D in pain management treatments
3.2.2 Industry pitfalls & challenges
3.2.2.1 Side effects caused by prolonged use of non-opioid pain patches
3.2.2.2 Availability of alternative treatments
3.3 Growth potential analysis
3.4 Regulatory landscape
3.4.1 U.S.
3.4.2 Europe
3.5 Technological landscape
3.5.1 Core technologies
3.5.2 Adjacent technologies
3.6 Reimbursement scenario
3.7 Pricing analysis
3.7.1 By region
3.7.2 By product
3.8 Consumer behavior analysis
3.9 Future market trends
3.10 Patent analysis
3.11 Profit margin analysis
3.12 Pipeline analysis
3.13 Clinical trial landscape
3.14 Gap analysis
3.15 Porter’s analysis
3.16 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Lidocaine patches
5.3 Diclofenac patches
5.4 Methyl Salicylate patches
5.5 Capsaicin patches
5.6 Ketoprofen patches
5.7 Other patches
Chapter 6 Market Estimates and Forecast, By Therapeutic Application, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Chronic pain
6.3 Acute pain
6.4 Neuropathic pain
6.5 Musculoskeletal pain
6.6 Other therapeutic applications
Chapter 7 Market Estimates and Forecast, By Distribution Channel, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Hospital pharmacies
7.3 Retail pharmacies
7.4 Online pharmacies
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Netherlands
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
Chapter 9 Company Profiles
9.1 Acorda Therapeutics
9.2 AdhexPharma
9.3 Endo Pharmaceuticals
9.4 Glaxo SmithKline
9.5 Grünenthal
9.6 Hisamitsu Pharmaceutical
9.7 IBSA Institut Biochimique
9.8 Johnson & Johnson
9.9 Mylan (Viatris)
9.10 Nichiban
9.11 Pfizer
9.12 ProSolus
9.13 Sanofi
9.14 Teikoku Seiyaku
9.15 Teva Pharmaceuticals
